Intrauterine myoma. Leiomyoma of uterus, unspecified
Conditions
Interventions
Intervention 1: Intervention group: Dienogest 2 mg tablets will be used for up to 4 weeks from the first day of menstruation. Dienogest is prepared under the brand name of Dinovel in the form of 2
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Reproductive ages Moderate to moderate abnormal uterine bleeding Do not receive hormonal medication for 8 weeks Submucosal myoma 30 mm or less in diameter in transvaginal ultrasound Submucosal myoma grade zero or I according to the classification of the European Society of Endoscopy and Gynecology
Exclusion criteria
Exclusion criteria: Cardiovascular disease Hepatic disease Renal disease Pulmonary disease Hematologic disease Hypertension Diabetes High triglyceride Thromboembolism History of uterine and cervical cancer History of submucosal leiomyoma larger than 3 cm History of acute genital infection History of the uterine septum Pregnancy Infertility Requires transfusion Severe bleeding Using anticoagulants
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Endometrial atrophy. Timepoint: 4 weeks after the intervention. Method of measurement: Vaginal ultrasound.;Bleeding during surgery. Timepoint: After surgery. Method of measurement: Operating room suction. | — |
Secondary
| Measure | Time frame |
|---|---|
| Clear image resolution. Timepoint: During surgery. Method of measurement: Observed by a gynecological surgeon.;Operation duration. Timepoint: During surgery. Method of measurement: Observed by a gynecological surgeon.;Success rate of myomectomy. Timepoint: During surgery. Method of measurement: Observed by a gynecological surgeon. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMehri Jaefari Shobeiri
Tabriz University of Medical Sciences
Outcome results
None listed